Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Comparison of HIIT and MICT and further detraining on metabolic syndrome and asprosin signaling pathway in metabolic syndrome model of rats.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: London : Nature Publishing Group, copyright 2011-
    • الموضوع:
    • نبذة مختصرة :
      Physical activity promotes various metabolic benefits by balancing pro and anti-inflammatory adipokines. Recent studies suggest that asprosin might be involved in progression of metabolic syndrome (MetS), however, the underlying mechanisms have not been understood yet. This study aimed to evaluate the effects of high-intensity interval training (HIIT), moderate-intensity continuous training (MICT), and further detraining on MetS indices, insulin resistance, serum and the liver levels of asprosin, and AMP-activated protein kinase (AMPK) pathway in menopause-induced MetS model of rats. A total of 64 Wistar rats were used in this study and divided into eight groups: Sham1, OVX1 (ovariectomized), Sham2, OVX2, OVX + HIIT, OVX + MICT, OVX + HIIT + Det (detraining), and OVX + MICT + Det. Animals performed the protocols, and then serum concentrations of asprosin, TNF-α, insulin, fasting blood glucose, and lipid profiles (TC, LDL, TG, and HDL) were assessed. Additionally, the liver expression of asprosin, AMPK, and P-AMPK was measured by western blotting. Both HIIT and MICT caused a significant decrease in weight, waist circumference, BMI (P = 0.001), and serum levels of glucose, insulin, asprosin (P = 0.001), triglyceride, total cholesterol, low-density lipoprotein (LDL), and TNF-α (P = 0.001), but an increase in the liver AMPK, P-AMPK, and P-AMPK/AMPK (P = 0.001), compared with OVX2 noexercised group. MICT was superior to HIIT in reducing serum asprosin, TNF-a, TG, LDL (P = 0.001), insulin, fasting blood glucose, HOMA-IR, and QUEKI index (P = 0.001), but an increase in the liver AMPK, and p-AMPK (P = 0.001). Although after two months of de-training almost all indices returned to the pre exercise values (P < 0.05). The findings suggest that MICT effectively alleviates MetS induced by menopause, at least partly through the activation of liver signaling of P-AMPK and the reduction of asprosin and TNF-α. These results have practical implications for the development of exercise interventions targeting MetS in menopausal individuals, emphasizing the potential benefits of MICT in mitigating MetS-related complications.
      (© 2024. The Author(s).)
    • References:
      Sports Med Health Sci. 2022 Jan 20;4(1):18-28. (PMID: 35782776)
      Clin Nutr. 2023 Mar;42(3):337-351. (PMID: 36736057)
      Diabetes. 2014 Aug;63(8):2800-11. (PMID: 24622799)
      Am J Obstet Gynecol. 2017 Apr;216(4):384.e1-384.e11. (PMID: 28024987)
      Exp Clin Endocrinol Diabetes. 2016 Nov;124(10):597-601. (PMID: 27657999)
      J Sci Med Sport. 2019 Apr;22(4):385-391. (PMID: 30803498)
      BMC Public Health. 2022 Oct 7;22(1):1869. (PMID: 36207719)
      Int J Environ Res Public Health. 2019 Feb 07;16(3):. (PMID: 30736402)
      Menopause. 2014 Sep;21(9):967-74. (PMID: 24496084)
      Cytokine Growth Factor Rev. 2021 Aug;60:120-132. (PMID: 34108103)
      J Nutr Health Aging. 2021;25(7):824-853. (PMID: 34409961)
      Heart Lung Circ. 2015 Feb;24(2):149-57. (PMID: 25306500)
      Int J Sports Med. 2021 Mar;42(3):199-214. (PMID: 33075830)
      Oxid Med Cell Longev. 2015;2015:787063. (PMID: 25874022)
      J Clin Endocrinol Metab. 2020 Aug 1;105(8):. (PMID: 32492705)
      Front Endocrinol (Lausanne). 2019 Aug 30;10:589. (PMID: 31543865)
      Life Sci. 2017 Nov 15;189:8-17. (PMID: 28893641)
      J Appl Physiol (1985). 2016 Jul 1;121(1):279-88. (PMID: 27255523)
      J Clin Med. 2019 May 12;8(5):. (PMID: 31083617)
      Open Access J Sports Med. 2018 Jan 26;9:1-17. (PMID: 29416382)
      Circulation. 1998 Jun 9;97(22):2283-93. (PMID: 9631884)
      J Physiol. 2008 Jan 1;586(1):151-60. (PMID: 17991697)
      Heart Lung Circ. 2016 Feb;25(2):166-74. (PMID: 26375499)
      Int J Environ Res Public Health. 2021 Dec 25;19(1):. (PMID: 35010479)
      Front Endocrinol (Lausanne). 2020 Feb 19;11:64. (PMID: 32153505)
      Cardiol Rev. 2016 Nov/Dec;24(6):273-281. (PMID: 27548688)
      Trials. 2018 Feb 27;19(1):144. (PMID: 29482601)
      Br J Pharmacol. 2011 May;163(2):424-37. (PMID: 21250975)
      Mol Cell Endocrinol. 2019 Apr 15;486:96-104. (PMID: 30853600)
      Int J Obes (Lond). 2008 Jun;32(6):949-58. (PMID: 18332882)
      Med Sci Sports Exerc. 2011 Jul;43(7):1334-59. (PMID: 21694556)
      Clin Chim Acta. 2019 Feb;489:183-188. (PMID: 29104036)
      Diabetes. 2013 Jul;62(7):2287-94. (PMID: 23493573)
      Diabetes Metab Syndr Obes. 2013 Jul 03;6:233-9. (PMID: 23847428)
      Br J Sports Med. 2020 Mar;54(6):341-348. (PMID: 29934430)
      Clin J Sport Med. 2014 Nov;24(6):513-8. (PMID: 24662570)
      Lifestyle Genom. 2019;12(1-6):25-44. (PMID: 31546245)
      Antioxid Redox Signal. 2013 Apr 1;18(10):1208-46. (PMID: 22978553)
      Exp Gerontol. 2021 Jul 15;150:111355. (PMID: 33865923)
      Nutrition. 2004 Jul-Aug;20(7-8):716-27. (PMID: 15212756)
      Prz Menopauzalny. 2019 Dec;18(3):166-173. (PMID: 31975984)
      Chronobiol Int. 2020 Aug;37(8):1252-1268. (PMID: 32741294)
      Front Physiol. 2018 Dec 10;9:1782. (PMID: 30618797)
      Clin Interv Aging. 2021 Apr 06;16:571-582. (PMID: 33854307)
      Eur J Cardiovasc Prev Rehabil. 2007 Dec;14(6):753-60. (PMID: 18043295)
      Int Urol Nephrol. 2020 Aug;52(8):1517-1522. (PMID: 32458209)
      J Cell Physiol. 2019 Nov;234(11):20888-20899. (PMID: 30997682)
      Br J Sports Med. 2017 Apr;51(8):670-676. (PMID: 27445361)
      Nat Rev Immunol. 2011 Feb;11(2):98-107. (PMID: 21233852)
      BMC Endocr Disord. 2022 Oct 8;22(1):245. (PMID: 36209084)
      Biology (Basel). 2021 Dec 04;10(12):. (PMID: 34943187)
      Cell. 2016 Apr 21;165(3):566-79. (PMID: 27087445)
      J Physiol Biochem. 2021 Feb;77(1):75-84. (PMID: 33428175)
      Gynecol Endocrinol. 2019 Mar;35(3):220-223. (PMID: 30325247)
      Appl Physiol Nutr Metab. 2013 Mar;38(3):326-33. (PMID: 23537026)
      Diabetol Metab Syndr. 2020 Jul 23;12:65. (PMID: 32714446)
      Biochem Res Int. 2015;2015:567945. (PMID: 25834745)
      Nutrition. 2019 Sep;65:173-178. (PMID: 31170681)
      Menopause. 2017 Dec;24(12):1404-1413. (PMID: 28654627)
      J Bone Miner Res. 2018 Dec;33(12):2140-2149. (PMID: 30088288)
      Obesity (Silver Spring). 2014 Oct;22(10):2137-46. (PMID: 25044799)
      Scand J Med Sci Sports. 2015 Dec;25 Suppl 3:1-72. (PMID: 26606383)
    • Contributed Indexing:
      Keywords: (MICT) moderate-intensity continuous training; Asprosin; Diabetes; High-intensity interval training (HIIT); Insulin resistance; Metabolic syndrome
    • الموضوع:
      Date Created: 20240517 Date Completed: 20240517 Latest Revision: 20240521
    • الموضوع:
      20240521
    • الرقم المعرف:
      PMC11101655
    • الرقم المعرف:
      10.1038/s41598-024-61842-5
    • الرقم المعرف:
      38760452